What KBNP does

KBNP (고려비엔피) is a South Korean veterinary pharmaceutical manufacturer founded in 1988, incorporated as a stock company (주식회사) and headquartered in Yesan-gun, Chungcheongnam-do, with a business office in Anyang-si, Gyeonggi-do. The company manufactures and sells veterinary pharmaceuticals across seven animal segments — poultry, swine, cattle, companion animals, aquaculture, beekeeping, and goats — organized into four product categories: vaccines, treatments, nutritional supplements, and disinfectants, totaling more than 200 SKUs. Its flagship is the Himmvac (힘백) vaccine brand, produced at Korea's largest domestic animal vaccine production facility with KVGMP certification, 8 independent production units, and 210+ Grade A–D clean rooms.

KBNP's technology base centers on recombinant vaccine development, including the world's first PCV2d VLP vaccine (Himmvac DonHoBang Circo 2D Plus), PRRS inactivated vaccines, and FMD E2 marker vaccines, supported by bacteriological and viral isolation/identification, antigen purification, and protein expression capabilities. R&D is conducted at an in-house Technical Research Institute staffed with Masters, PhD, and Bachelors-level researchers, complemented by international collaborations including a 2017 partnership with KAIST on honeybee therapeutics (Barokil-P) and WOAH certification of its rabies neutralizing antibody testing laboratory through France's Anses. The intellectual property portfolio comprises 43 registered patents (35 domestic, 8 overseas spanning the US, China, Japan, and Vietnam) and 11 pending applications.

The business model is product sales across the veterinary pharmaceutical value chain. Domestically, KBNP distributes through livestock pharmaceutical retailers, veterinary hospitals, feed factories, large-scale farms, and the Korea Public Procurement Service (조달청); internationally, it exports to over 30 countries. The company is led by Representative Director Song Han-i and is privately held with no disclosed institutional investors or parent company. Pricing is not publicly disclosed; products are sold both commercially and via government tender, with revenue and ARR figures not publicly reported.

Name

KBNP

Legal name

주식회사 고려비엔피

Website

https://kbnp.co.kr

Company type

Private

Founded year

1988

Operating status

Operating

Headcount range

101–250 employees

Short description

KBNP (고려비엔피) is a South Korean veterinary pharmaceutical manufacturer founded in 1988 that produces 200+ vaccines, treatments, nutritional supplements, and disinfectants across seven animal segments at Korea's largest KVGMP-certified Himmvac vaccine facility, distributing domestically through retailers, veterinarians, farms, and the Korea Public Procurement Service and exporting to 30+ countries.

Ownership category

akta.pro rank

Product category

Veterinary Pharmaceuticals

NAICS

Biological Product (except Diagnostic) Manufacturing (325414), Pharmaceutical Preparation Manufacturing (325412)

SIC

Biological Products, (No Disgnostic Substances) (2836), Pharmaceutical Preparations (2834)

akta.pro primary industry

Veterinary Vaccines (Biologics) (HLAMAEAL)

akta.pro secondary industries

Vaccine R&D, Clinical/Field Trials & Regulatory Affairs (HLAMAKAM), Veterinary Vaccine & Biologics Distributors (HLAMAIAC), Companion Animal Vaccines (Dogs & Cats) (HLAMAKAA)

Keywords

• Veterinary pharmaceuticals
• Animal vaccines
• Livestock health products
• Veterinary disinfectants
• Animal nutrition supplements

Headquarters

HQ city

Yesan

HQ country

South Korea

HQ region

Asia

Offices4 records

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Operations, Personnel, Technology or R&D, Marketing or Sales, Infrastructure, Supply Chain

Revenue model

1. Veterinary Pharmaceutical Products: Manufacture and sale of veterinary pharmaceuticals including vaccines, injectables, feed additives, liquids, disinfectants, and fermented microbial products. Products sold domestically through retailers, veterinary hospitals, feed factories, and large farms, and exported to over 30 countries worldwide.

Go-to-market motion1 record

Distribution channels5 records

Marketing channels5 records

Core offering

KBNP manufactures and sells veterinary pharmaceuticals including vaccines, treatments, nutritional supplements, and disinfectants for livestock and companion animals. The company's flagship Himmvac brand produces vaccines for poultry, swine, cattle, aquaculture, and companion animals at Korea's largest KVGMP-certified facility. With 200+ products across seven animal segments and exports to 30+ countries, KBNP also offers WOAH-certified rabies antibody testing services.

Product overview

KBNP (고려비엔피) is a veterinary pharmaceutical company established in 1989, specializing in animal healthcare products across seven segments: poultry (양계), pig (양돈), cattle (축우), companion animals (반려동물), aquaculture (양어), beekeeping (양봉), and goats (염소). The company manufactures over 200 products including vaccines, treatments, nutritional supplements, and disinfectants. Its flagship is the 힘백 (Himmvac) vaccine brand, produced at Korea's largest animal vaccine facility with KVGMP certification. Products are organized into four categories: vaccines (백신), treatments (치료제), nutritional supplements (영양제/생산성 향상제), and disinfectants (소독제/환경개선제). Notable products include K-이지플루, 마크로틸 250 액, 메타콜 액, 힘백 돈호방 써코 2D 플러스 주 (world's first PCV2d VLP vaccine), 힘백 DHPP, and various disinfectants like 라이프자켓 and 수산용 라이프자켓. The company exports to over 30 countries worldwide.

Differentiator

Problem solved

Functional benefit

Brands

• 힘백(Himmvac): Premium animal vaccine brand producing vaccines for poultry, swine, cattle, aquaculture, and companion animals. 힘백 공장은 국제 규격의 첨단 시설을 갖춘 국내 최대규모의 동물용 백 신 생산공장.
• nolbaetter 놀배터

Products and services

• Himmvac Brand Veterinary Vaccines KBNP's flagship vaccine brand producing vaccines for poultry (Newcastle disease, avian influenza, infectious bronchitis, Marek's disease), swine (PCV2d VLP, PRRS, FMD), cattle, companion animals (DHPP, rabies), and aquaculture. Includes the world's first PCV2d VLP vaccine (Himmvac DonHoBang Circo 2D Plus) and government-procurement-listed poultry vaccines (Himmvac DalGooBang series).
• Veterinary Pharmaceutical Treatments Antibiotic and anti-infective treatments for livestock including K-Eziflu (Florfenicol solution), Macrotil 250 Liquid (tilmicosin), Metacol Liquid (E. coli/mycoplasma), Metaflu Forte (triple-effect florfenicol), Kafuran 200 Liquid (apramycin), Tullexin Injection (pneumonia), Donpas San (comprehensive treatment), and Kaspirin-C (antipyretic analgesic for FMD vaccination stress relief).
• Animal Nutritional Supplements and Productivity Enhancers Feed additives and nutritional supplements including Cosemin (immune booster with 19 ingredients), WeDon Care (gastritis/gastric ulcer management for pigs), HanQ Pet Piglet Formula (triple bio-enhanced piglet feed additive), Usabang IgY (immune antibody supplement for calves), Vigoin-S (metabolic promoter from Ceva France), Titan (injectable metabolic promoter), and Energy Source (beekeeping immune enhancer).
• Veterinary Disinfectants and Environmental Products Disinfectants effective against FMD, ASF, and avian influenza including LifeGuard-Tablet (UK Pirbright Institute certified for FMD), Lifeline (ultra-strong disinfectant against ASF/FMD/AI), Life Jacket (FMD/AI certified by Pirbright), Life Jacket-Tablet (patented triple-salt foaming disinfectant), Life Clean K (FMD/swine fever/Newcastle disease), Doctor Fish (eco-friendly aquaculture disinfectant), and Beekeeping Life Jacket-Tablet (honeybee disinfectant for foulbrood virus).
• Aquaculture Health Products Specialized vaccines and treatments for fish farming including Natural Scutchi Stop (flounder scuticociliatosis treatment), Aquatic Avante Injection (cephalosporin antibiotic), Aquatic Erycin (erythromycin), and Aquatic Kamoxin Injection (amoxicillin sodium).
• Beekeeping Treatment Products Honeybee health products including Barokil-P (varroa mite treatment co-developed with KAIST), Fumidil-B Powder (nosema disease treatment), and Energy Source (immune enhancer).
• Companion Animal Health Products Pet vaccines and supplements including Himmvac DHPP (comprehensive canine vaccine), Himmvac CaniFun LV Inactivated Vaccine (rabies vaccine), Campicillin Injection (broad-spectrum antibiotic), Parino 25WP (fly larvae control), Vigoin-S and Titan (metabolic promoters).
• Rabies Neutralizing Antibody Testing Service WOAH-certified laboratory service for rabies neutralizing antibody testing for pet export/import, accredited through France's Anses (WOAH Standard Laboratory) and listed on the EU website.

Quantifiable outcome

• Products exported to 30+ countries with quality recognition
• +2 more outcomes

Named customers3 records

Segments7 records

Ideal customer profiles4 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature4 records

Partnerships

Four partnerships are on record, tiered core and major.

• 한국과학기술원 (Korea Advanced Institute of Science and Technology, KAIST)coreStrategic or Co-development Partner · 1 January 2017Joint development of Barokil-P, a varroa mite treatment for honeybees using technology developed in collaboration with KAIST.
• 성일파마 (Sungil Pharma)majorOthers · 1 January 2007KBNP merged with Sungil Pharma in 2007, combining pharmaceutical capabilities and expanding product portfolio.
• Bayer Korea (바이엘코리아)majorOthers · 1 January 2001KBNP acquired Bayer Korea's vaccine business division in 2001, significantly enhancing its vaccine manufacturing capabilities and market position.
• French Anses (WOAH Standard Laboratory)coreTechnology or IntegrationKBNP's laboratory received WOAH (World Organisation for Animal Health) certification through France's Anses, recognized on EU website as an official testing laboratory for rabies neutralizing antibodies.

Scale indicators6 records

Recent moves13 records

Expansion highlights6 records

Direct peers

• Choong Ang Vaccine Laboratories: Korean veterinary vaccine manufacturer and one of KBNP's most direct domestic competitors, producing vaccines for poultry, swine, and cattle. Operates similar KVGMP-certified production facilities in Korea and exports to Asian markets, making it the closest head-to-head peer.
• Komipharm International: Korean animal health pharmaceutical company specializing in veterinary vaccines and pharmaceuticals. Competes with KBNP across multiple livestock segments in the Korean market and selected export geographies.
• Kyoritsu Seiyaku Corporation: Japanese veterinary pharmaceutical and biological products manufacturer with a similar profile of livestock and companion animal vaccines, feed additives, and disinfectants. Comparable mid-sized animal health player competing in the broader East Asian market.
• Nippon Zenyaku Kogyo (Zenoaq): Japanese animal health pharmaceutical company producing veterinary vaccines, pharmaceuticals, and diagnostics. Comparable scale and product breadth across companion animals and livestock, serving as a regional peer in Asia.

Broad incumbents

• Ceva Santé Animale: Global top-5 animal health company headquartered in France with broad vaccines, pharmaceutical, and biosecurity portfolio. KBNP even sources one of its companion animal products (Vigoin-S) from Ceva, indicating the two have an established supplier/customer relationship alongside competitive overlap.
• Virbac: French global animal health company focused on vaccines, pharmaceuticals, and diagnostics across companion animals and livestock. Larger but comparable in product breadth to KBNP, competing in many of the same emerging market geographies.
• Huvepharma: Bulgarian-headquartered global animal health company with vaccines, pharmaceuticals, and feed additives. Similar mid-cap positioning with strong focus on livestock segments and a pattern of growth through acquisition in emerging markets — comparable strategic profile to KBNP.
• Vetoquinol: French global animal health pharmaceutical company with a portfolio spanning livestock and companion animal pharmaceuticals and vaccines. Similar mid-cap profile and direct competitive overlap in key Asian and Latin American markets.
• Phibro Animal Health: US-listed global animal health and mineral nutrition company with vaccines, pharmaceuticals, and feed additives across livestock species. Comparable mid-cap scale and product mix, with broad emerging market footprint that overlaps KBNP's export geographies.

Emerging players

• Indian Immunologicals: Indian veterinary vaccine manufacturer owned by the National Dairy Development Board, producing animal vaccines including livestock and aquaculture. Comparable in emerging-market positioning and recombinant vaccine capability, competing in similar export geographies.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

Compliance3 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about KBNP